Xenon Pharmaceuticals Inc. - Common Stock (XENE)

236 filings reported holding XENE - Xenon Pharmaceuticals Inc. - Common Stock as of Q1 2025.
Xenon Pharmaceuticals Inc. - Common Stock (XENE) has 206 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 76.7M shares of 77.3M outstanding shares and own 99.2% of the company stock.
Largest 10 shareholders include FMR LLC (8.29M shares), Avoro Capital Advisors LLC (5.74M shares), Driehaus Capital Management LLC (4.58M shares), WELLINGTON MANAGEMENT GROUP LLP (3.79M shares), JANUS HENDERSON GROUP PLC (3.33M shares), Capital International Investors (3.09M shares), BRAIDWELL LP (2.71M shares), Polar Capital Holdings Plc (2.62M shares), COMMODORE CAPITAL LP (2.33M shares), and Capital World Investors (2.22M shares).
This table shows the top 206 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.